PORTLAND, Oregon, August 31, 2016 /PRNewswire/ --
According to a new report by Allied Market Research, titled, "COPD and Asthma Devices Market - Global Opportunity Analysis and Industry Forecast, 2015 - 2022", the Global COPD and asthma devices market is expected to reach $41,355.2 million by 2022. The drug powder inhaler was the highest revenue-generating segment, accounting for over half of the share in 2015. This segment is expected to maintain its dominance throughout the forecast period.
The major factors boosting the market growth include increasing prevalence of respiratory diseases such as COPD, asthma, and emphysema; growing need for rescue medication during sudden asthmatic attack; and burgeoning demand for short-term, effective medication, says Deepa Tatkare, Lead Analyst at Allied Market Research. Increasing focus of manufacturers towards the development of advanced and portable inhalation devices would further boost the market growth, she adds. The factors hampering the market growth include environmental concerns associated with metered dose inhalers (MDI) and high cost of selected inhalation devices. Regulatory authorities such as U.S. food and drug administration (USFDA) across several regions have banned the production and sales of MDIs, as they release environmentally hazardous gases such as chlorofluorocarbon (CFC) and hydrofluoroalkanes (HFA). Thus, soft mist inhalers (SMIs) and nebulizers are expected to replace MDIs for the treatment of respiratory diseases in the near future.
Compressor nebulizers constitute around four-fifths share of the overall nebulizers market, owing to their perpetual usage in home healthcare medication and widespread availability across various regions. Nebulizers are electric- or battery-powered machines, which dispense the medication in the form of fine mist. They are used in home healthcare set-ups for debilitated patients, geriatric, and children. However, the large size of nebulizers and the need for continuous power supply are expected to hinder the market growth.
Sample of the COPD and Asthma Devices Market Report can be accessed on the website at https://www.alliedmarketresearch.com/COPD-asthma-devices-market
Drug powder inhalers (DPIs) segment is projected to grow at a significant CAGR of 5.7% during the forecast period.
North America was the leading region in 2015, and is expected to continue its dominance throughout the analysis period.
The COPD and asthma devices market in Europe is projected to grow at a CAGR of 6.1%.
The compressor nebulizers segment is expected to register a CAGR of 5.4%.
North America is expected to remain the highest revenue-generating region, owing to widespread and early adoption of inhalers & nebulizers and large pool of patients suffering from respiratory diseases. Moreover, the Asia-Pacific region is expected to grow rapidly due to rising healthcare expenditure, growing awareness of advanced portable COPD & asthma devices, and increasing disposable income.
The key product manufacturing companies profiled in this report include GlaxoSmithKline Plc, Novartis AG, Merck & Co., Inc., AstraZeneca Plc, Philips Healthcare, 3M Health Care, Allied Healthcare Products, Inc., Sunovion Pharmaceuticals, Inc., GF Healthcare Products, Smith Medicals, Inc., Lincare Holdings, Inc., and Baxter International.
Similar Reports Published by Allied Market Research -
Anesthesia and Respiratory Devices Market - https://www.alliedmarketresearch.com/anesthesia-and-respiratory-devices-market
Drug-Device Combination Products Market - https://www.alliedmarketresearch.com/drug-device-combination-products-market
Allied Market Research (AMR) is a full-service market research and business consulting wing of Allied Analytics LLP, based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions". AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies, and this helps us in digging out market data that helps us generate accurate research data tables and confirm the utmost accuracy in our market forecasting. All the data presented in the reports published by us are extracted through primary interviews with top officials from leading companies of concerned domain. Our secondary data procurement methodology includes deep online and offline research and discussions with knowledgeable professionals and analysts in the industry.
5933 NE Win Sivers Drive,
#205, Portland, OR 97220,
Toll Free: +1-800-792-5285
For more information:
Last updated on: 31/08/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.